After enjoying a week in Tenby, Richard Hattersley returns to the podcast to discuss Companies House reforms. While Companies House confirmed small companies will be required to file their profit and loss (P&L) accounts, doubts quickly followed. Hattersley unpacks where the reforms stand, the debate around P&L filing and why the situation has become so unclear.

Back from Norway, Tom Herbert takes a look at the audit market and shares his growing concerns about the role of auditors. He draws on David Graeber’s “Bullshit Jobs” concept, where people feel their work lacks real purpose, and wonders if audit is heading in that direction. Once seen as a pillar of financial integrity, audit may be losing its meaning. Herbert reflects on what this could mean for attracting new talent, the growing skills gap and the deeper identity crisis facing the profession.

Matthew Ord shares a new ICAEW report on the evolution of mid-tier accountancy firms, highlighting that many still aren’t convinced by private equity. He runs through some of the findings, as the team explores why some independent firms remain cautious, whether we’ll ever agree on whether PE is good or bad and how the ongoing skills gap continues to shape the conversation.


No Accounting for Taste ep193: What is happening with P&L filing?

Episode 32 - M&A in the Global Agri-Food Industry - July 2025


The IPO market remains unwelcoming to biotechs and venture investors are reticent to back younger companies. In the absence of reliable funding sources, many biotechs are trying to advance their most promising programs while keeping their operations lean until they can get to a fundable milestone. We spoke to Kevin Sarney, Life Sciences Practice Leader for Charles River CFO, about the current uncertainty biotechs face, the need for capital efficiency, and how companies can best prepare for future opportunities.

Surviving and Thriving in the Long Biotech Winter

Episode 33 - M&A in the Global Agri-Food Industry - August 2025

Trent breaks down the big news: Specialty Building Products signing an agreement to acquire OrePac Building Products and National Lumber picking up Fisher Lumber - what it means for consolidation, brands, and the West Coast footprint. We shout out Alpinewest Resources’ new VP of Finance, and plug Traders Market in Kansas City (steakhouse waitlist, anyone?). Natalie weighs the quarter-point rate cut vs. housing inertia, we chat equity, renting vs. owning, and where 30-year mortgages are landing. We wrap with a quick price check. Questions or comments? Email us at lumberslingers@gmail.com

119. Newswire Update: Big M&A Hits the West Coast

IB 4 Lyfe

CEO of KLN Charlie Nelson and Co-founder of Finley’s Kyle Gallus answer the question, "How can mergers and acquisitions happen without a company losing its brand mission and purpose?"

Ethical M&A with Charlie Nelson of KLN and Kyle Gallus of Finley's

***New Video Alert!

Thinking about selling your small business now or maybe a few years down the road?

In this week’s video, I’m breaking down the top five mistakes that quietly destroy business sales before they ever reach the finish line.

We’ll talk about why sloppy books kill credibility with buyers and banks, how a “you-dependent” business scares off deals, and why waiting too long to prepare might mean missing your best shot at selling.

Whether you’re planning to sell soon or someday, this one will help you see your business through a buyer’s eyes and avoid the traps that make good companies unsellable.

Watch here: https://youtu.be/V-63WwII-TI 

Talk soon,

David C. Barnett

****
- Join David's email list so you never miss any new videos or important information or insights, RECEIVE 7 FREE GIFTS!!-  https://www.DavidCBarnettList.com
****
Do Business with David using these incredible internet links...

- David's Blog where you can find hundreds of free videos and articles, https://www.DavidCBarnett.com

- Book a call with David and let him help you with your project, https://www.CallDavidBarnett.com

- Learn how to buy a successful and profitable business in a risk-controlled way https://www.BusinessBuyerAdvantage.com

- Get help selling your business, https://www.HowToSellMyOwnBusiness.com

- Get better organized in your business, https://www.EasySmallBizSystems.com

- Learn to make better cash flow forecasts and write incredibly effective business plans from scratch!, https://www.BizPlanSchool.com

- Learn to build an equity asset with insurance! visit https://www.NewBankingSolution.com

-Did you sign up for an expensive Merchant Cash Advance for your business and now struggle to make the payments? Find out how you can negotiate your way out at https://www.EndMyMCA.com



Buy a Business

Top 5 Biggest Mistakes when trying to sell a business

Joseph Haas, senior writer, Scrip, speaks to guest panelists Robert Darwin, partner, Sidley law firm, and Arda Ural, Americas Life Sciences Leader, EY. 

Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space?

Audio roundup of selected biopharma industry content from Scrip over the business week ended October 31, 2025. In this episode: third quarter dealmaking picks up; Novartis still has M&A firepower even after Avidity acquisition; Hanmi’s obesity contender shows Phase III promise; NVIDIA partnership progresses Lilly’s AI plans; and Lilly builds gene therapy push with Adverum buy. 

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-MQMX2YHSAVHBTJFR4RAEAYNFNQ/

This episode was produced with the help of AI text-to-voice and voice emulation tools.

Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Scrip's Five Must-Know Things - Nov. 4, 2025

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月31日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。

本次要闻: 本期要闻——第三季度并购交易回暖； 诺华收购Avidity后并购火力依旧；韩美制药肥胖症候选药物展现三期试验潜力；英伟达合作推动礼来人工智能计划；礼来收购Adverum强化基因疗法布局。

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-MQMX2YHSAVHBTJFR4RAEAYNFNQ/

Playlist: on.soundcloud.com/gnr7PaOwflNKiAO7QX



Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年11月1日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。

本次要闻: 辉瑞对Metsera的坚定收购计划；礼来公司肥胖症治疗领域的强劲势头；默克公司MFN协议谈判进展；诺华公司干燥综合征研究的积极成果；以及中国对美国创新领域施加的日益增大的压力。

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-2K33BM6BLBDU7JH7QMETUXUKPE/

Playlist: on.soundcloud.com/gnr7PaOwflNKiAO7QX

In this episode of Nevermind The Pain Points, we dive into the complexities and challenges organisations face during post-merger and acquisition (M&A) transformations. 

Host and Clarasys Subscription and Customer Experience Practice Lead Tom Carpenter is joined by Rebecca Clark of Sojourn Solutions, a marketing operations consultancy, and Moray Busch, who heads the M&A practice at Clarasys, to explore how to successfully navigate integration. 

The discussion focuses on the need for early preparation, including setting a clear vision and involving on-the-ground teams from the start, as well as the importance of establishing clear decision-making authority and governance to operationalise the program. They outline the critical roles for an effective integration team, including C-suite sponsorship, SMEs, and a product ownership function to manage technology and business tension. Ultimately, they argue that M&A is an opportunity for transformative change, advocating for using Customer Experience (CX) to resolve internal conflicts and urging companies to adopt a 'greenfield' architectural mindset over simply performing a transactional 'find-and-replace' integration. 

Packed with practical advice on people, process, and technology, this episode is a must-listen for anyone involved in an M&A transformation program. 

Listen here or visit our website for the transcript: https://clarasys.com/insights/thinking/podcast/navigating-post-merger-integration-challenges-and-opportunities

Post-merger integration: Navigating challenges and opportunities | Clarasys x Sojourn

Audio roundup of selected biopharma industry content from Scrip over the business week ended November 21, 2025. In this episode: obesity beyond GLP-1s; biotech leaders bullish as M&A heats up; BMS’s milvexian setback; clinicians on evolution of MASH treatment; and Japan H1 results mixed. 

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-MXUR6OEDNNAEPPTTZ4YZKH55SU/

This episode was produced with the help of AI text-to-voice and voice emulation tools.

Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Scrip's Five Must-Know Things - Nov. 25, 2025

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年11月21日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。

本次要闻: GLP-1药物之外的肥胖治疗新局；并购热潮中生物科技巨头的乐观预期；百时美施贵宝Milvexian遭遇挫折；临床专家解读MASH疗法演进；日本企业上半年业绩喜忧参半。

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-MXUR6OEDNNAEPPTTZ4YZKH55SU/

Playlist: on.soundcloud.com/gnr7PaOwflNKiAO7QX

최근 런던에서 열린 Jefferies 글로벌 헬스케어 컨퍼런스를 취재한 Scrip기사를 요약한 내용입니다

https://insights.citeline.com/scrip/business/start-ups-and-smes/jefferies-25-biotech-leaders-bullish-as-ma-heats-up-EAHTR2MNHJE65E74WLIMBXXK5I/

 Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini

 

글로벌 바이오 리더들, M&A 열기 속 낙관론 확산 (Korean-language podcast)

Audio roundup of selected biopharma industry content from Scrip over the business week ended December 5, 2025. In this episode: Trump’s UK drug pricing win; Novo explains semaglutide Alzheimer's rationale; J&J and Novartis on this year’s biggest M&A deals; a look at the mixed performance of CAR-Ts; and Akeso’s goals beyond ivonescimab. 

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-UZSVLBBSQRAKNJC7GDZWILMAT4/

This episode was produced with the help of AI text-to-voice and voice emulation tools.

Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things

Scrip's Five Must-Know Things - Dec. 8, 2025

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年12月5日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。

本次要闻: 特朗普在英国药品定价谈判中获胜；诺和诺德阐释司美格鲁肽治疗阿尔茨海默病的依据；强生与诺华达成年度最大并购交易；CAR-T疗法成效参差分析；阿克索制药的伊沃尼西马布后续目标。

Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-UZSVLBBSQRAKNJC7GDZWILMAT4/

Playlist: on.soundcloud.com/gnr7PaOwflNKiAO7QX



Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.

The pet food industry is a constantly evolving landscape of trends and consumer needs. Join Petfood Industry magazine Editor Lindsay Beaton every other Wednesday as she interviews industry experts and covers hot topics affecting the world of pet food. If pet food is your thing and you want to know what’s trending, tune in!
Brought to you by Petfood Industry and WATT Global Media

I discuss buying, selling, financing and managing small and medium sized businesses either alone or with guests.  
I've started, bought, sold and closed businesses. 
Author of three best-selling business books; 'Invest Local: a guide to superior investment returns in your own community,' 'Franchise Warnings: What you really need to know before you buy' and 'How To Sell My Own Business: A guide to selling your own business without paying a broker's commission.' all available as well as 5 other books on Amazon or from www.DavidCBarnett.com

Amateur music artist, crypto and NFT enthusiast, Suno AI fanatic, Dad

The Big4Bio Podcast shares podcasts that give insight and information about/from biotech and life science leaders and organizations within the Big4Bio regions. Check out our Playlists to hear podcasts by region.

Never Mind the Pain Points, hosted by Clarasys, is a podcast dedicated to all the current challenges businesses are facing. Each episode is hosted by a Clarasys employee, that has deep expertise in the subject matter of each episode. The hosts are joined by a variety of fantastic, interesting and knowledgable guests from the world of business and together they discuss pain points that organisations face and what you can do to overcome them! 

Whether you are a part of an organisation that face these problems and are looking for ways to overcome them or you just have a strong interest in knowing more about the topics covered, then this is the podcast for you!

Each podcast we bring relevant and useful industry information including interviews with top lumber professionals and discussion of current events in the industry. Whether it be lumber grading, industry and market trends, or who-is-who in lumber, we hope to extend your current tally on industry knowledge.

New tracks tagged #M&amp;A

New tracks tagged #M&A